We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+10.72%
1 Year Est. Return
+80.99%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.85B
AUM Growth
+$338M
Cap. Flow
+$79.4M
Cap. Flow %
1.36%
Top 10 Hldgs %
45.51%
Holding
707
New
76
Increased
198
Reduced
354
Closed
64

Top Buys

Rank Stock Value
1
TER icon
Teradyne
TER
+$60.1M
2
TSLA icon
Tesla
TSLA
+$32.1M
3
TSEM icon
Tower Semiconductor
TSEM
+$29.6M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$29M
5
PDD icon
Pinduoduo
PDD
+$28.1M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$77.7M
2
BE icon
Bloom Energy
BE
+$53.1M
3
HOOD icon
Robinhood
HOOD
+$24.9M
4
SAP icon
SAP
SAP
+$24.1M
5
BIDU icon
Baidu
BIDU
+$21.5M

Sector Composition

Rank Sector Weight
1 Technology 51.21%
2 Communication Services 15.38%
3 Consumer Discretionary 13.01%
4 Healthcare 6.62%
5 Consumer Staples 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
151
Pfizer
PFE
$144B
$3.86M 0.07%
155,118
-2,931
-2% -$73.9K
V icon
152
Visa
V
$697B
$3.79M 0.06%
10,818
+10,000
+1,222% +$3.41M
MDT icon
153
Medtronic
MDT
$111B
$3.34M 0.06%
34,749
-656
-2% -$63.7K
SYK icon
154
Stryker
SYK
$133B
$3.27M 0.06%
9,309
-174
-2% -$63.4K
ARM icon
155
Arm
ARM
$261B
$3.19M 0.05%
29,183
+2,539
+10% +$369K
CVS icon
156
CVS Health
CVS
$140B
$3.1M 0.05%
39,118
-649
-2% -$51.2K
BMY icon
157
Bristol-Myers Squibb
BMY
$130B
$2.99M 0.05%
55,513
-1,047
-2% -$50.4K
AR icon
158
Antero Resources
AR
$10.5B
$2.98M 0.05%
86,533
+7,356
+9% +$249K
DIS icon
159
Walt Disney
DIS
$172B
$2.96M 0.05%
+26,000
New +$2.86M
OVV icon
160
Ovintiv
OVV
$16.4B
$2.95M 0.05%
75,199
+4,724
+7% +$183K
PR
161
Permian Resources
PR
$16.5B
$2.89M 0.05%
205,792
+32,807
+19% +$441K
MCK icon
162
McKesson
MCK
$104B
$2.79M 0.05%
3,397
-62
-2% -$50.6K
APA icon
163
APA Corp
APA
$12.3B
$2.56M 0.04%
104,615
+6,737
+7% +$163K
RRC icon
164
Range Resources
RRC
$8.94B
$2.45M 0.04%
69,406
+4,583
+7% +$171K
ALAB icon
165
Astera Labs
ALAB
$44.6B
$2.18M 0.04%
13,104
-54,968
-81% -$9.2M
DG icon
166
Dollar General
DG
$27.8B
$2.17M 0.04%
16,321
-23,668
-59% -$2.64M
DINO icon
167
HF Sinclair
DINO
$16.1B
$2.11M 0.04%
45,799
+2,358
+5% +$122K
HCA icon
168
HCA Healthcare
HCA
$92.8B
$2.07M 0.04%
4,433
-310
-7% -$144K
WELL icon
169
Welltower
WELL
$175B
$2.06M 0.04%
11,082
+150
+1% +$28K
SE icon
170
Sea Limited
SE
$65.8B
$2.02M 0.03%
15,799
-12,973
-45% -$1.92M
CI icon
171
Cigna
CI
$79.6B
$2M 0.03%
7,252
-135
-2% -$37.8K
PLD icon
172
Prologis
PLD
$137B
$1.96M 0.03%
15,387
-52
-0.3% -$6.48K
QFIN icon
173
Qfin Holdings
QFIN
$1.66B
$1.96M 0.03%
101,719
-4,675
-4% -$105K
VNOM icon
174
Viper Energy
VNOM
$8.21B
$1.92M 0.03%
49,791
+4,026
+9% +$152K
AFRM icon
175
Affirm
AFRM
$24.2B
$1.82M 0.03%
24,491

Similar funds

GF Fund Management's Q4 2025 Portfolio in Review

As of Q4 2025, GF Fund Management held 707 positions worth $5.85B, up 6.1% from $5.51B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q4 2025 filing shows 76 new, 198 increased, 354 reduced and 64 closed positions. Its largest new stake was Teradyne: 350,137 shares worth $67.8M. The largest sale was Broadcom, an estimated $77.7M.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 49% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q4 2025 buy was Teradyne: 350,137 shares worth $67.8M.
  • GF Fund Management added most to Tesla in Q4 2025, an estimated $32.1M increase.
  • GF Fund Management's biggest Q4 2025 reduction was Broadcom, cutting an estimated $77.7M.
  • GF Fund Management fully exited Baidu in Q4 2025, selling an estimated $21.5M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.85B portfolio in Q4 2025.
  • GF Fund Management opened 76 new positions and closed 64 in Q4 2025.
  • GF Fund Management's portfolio value rose 6.1% quarter-over-quarter to $5.85B.

Based on GF Fund Management's 13F filing for Q4 2025, filed 27 Jan 2026.